...
首页> 外文期刊>Cell metabolism >The Itaconate Pathway Is a Central Regulatory Node Linking Innate Immune Tolerance and Trained Immunity
【24h】

The Itaconate Pathway Is a Central Regulatory Node Linking Innate Immune Tolerance and Trained Immunity

机译:itAconate途径是一种连接先天免疫耐受性和培训的免疫力的中央调节节点

获取原文
获取原文并翻译 | 示例
           

摘要

Sepsis involves simultaneous hyperactivation of the immune system and immune paralysis, leading to both organ dysfunction and increased susceptibility to secondary infections. Acute activation of myeloid cells induced itaconate synthesis, which subsequently mediated innate immune tolerance in human monocytes. In contrast, induction of trained immunity by beta-glucan counteracted tolerance induced in a model of human endotoxemia by inhibiting the expression of immune-responsive gene 1 (IRG1), the enzyme that controls itaconate synthesis. beta-Glucan also increased the expression of succinate dehydrogenase (SDH), contributing to the integrity of the TCA cycle and leading to an enhanced innate immune response after secondary stimulation. The role of itaconate was further validated by IRG1 and SDH poly-morphisms that modulate induction of tolerance and trained immunity in human monocytes. These data demonstrate the importance of the IRG1-itaconate-SDH axis in the development of immune tolerance and training and highlight the potential of beta-glucan-induced trained immunity to revert immunoparalysis.
机译:脓毒症涉及同时同时激活免疫系统和免疫瘫痪,导致器官功能障碍和对二次感染的易感性增加。骨髓细胞急性活化诱导汽康酸盐合成,随后介导人单核细胞的先天免疫耐受性。相反,通过抑制免疫响应基因1(IRG1)的表达,通过抑制控制迭科合成的酶,通过β-葡聚糖诱导培训的免疫诱导诱导人内毒血症模型中的耐受性。 β-葡聚糖还增加了琥珀酸酯脱氢酶(SDH)的表达,有助于TCA循环的完整性,并导致继发刺激后提高先天免疫应答。 IRG1和SDH多态源进一步验证了迭科的作用,其调节诱导人单核细胞中耐受性和培训的免疫力。这些数据证明了IRG1-itAconate-SDH轴在免疫耐受性和培训开发中的重要性,并突出β-葡聚糖诱导的培训免疫力恢复免疫分析的潜力。

著录项

  • 来源
    《Cell metabolism》 |2019年第1期|共15页
  • 作者单位

    Radboud Univ Nijmegen Dept Internal Med 463 Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Fac Sci Dept Mol Biol NL-6525 GA Nijmegen Netherlands;

    Univ Med Ctr Groningen Dept Genet Groningen Netherlands;

    Univ Amsterdam Ctr Expt &

    Mol Med Amsterdam Med Ctr Div Infect Dis Amsterdam Netherlands;

    Radboud Univ Nijmegen Dept Internal Med 463 Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Dept Internal Med 463 Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Dept Internal Med 463 Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Dept Internal Med 463 Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Dept Internal Med 463 Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Radboud Ctr Infect Dis RCI Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Radboud Ctr Infect Dis RCI Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Dept Internal Med 463 Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Dept Internal Med 463 Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Univ Med Ctr Groningen Dept Genet Groningen Netherlands;

    Luxembourg Inst Hlth Dept Oncol NORLUX Neurooncol Lab Luxembourg Luxembourg;

    Univ Amsterdam Ctr Expt &

    Mol Med Amsterdam Med Ctr Div Infect Dis Amsterdam Netherlands;

    Radboud Univ Nijmegen Radboud Ctr Infect Dis RCI Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Radboud Ctr Infect Dis RCI Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Dept Internal Med 463 Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

    Radboud Univ Nijmegen Fac Sci Dept Mol Biol NL-6525 GA Nijmegen Netherlands;

    Radboud Univ Nijmegen Dept Internal Med 463 Med Ctr Geert Grootepl 8 NL-6500 HB Nijmegen;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内分泌腺疾病及代谢病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号